Efficacy and Safety of mRNA SARS-CoV2 Vaccination in Heart Transplant Recipients

PURPOSE: Data on immunologic response to SARS-CoV2 vaccination in heart transplant recipients are scarce. We investigated the efficacy and safety of mRNA SARS-CoV2 vaccination in this patient population. METHODS: In a retrospective single-center study we included 54 consecutive adult heart transplan...

Descripción completa

Detalles Bibliográficos
Autores principales: Poglajen, G., Ihan, A., Žorž, N., Frljak, S., Petek, S., Pohar, K., Cerar, A., Zemljič, G., Okrajšek, R., Šebeštjen, M., Kneževič, I., Vrtovec, B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2022
Materias:
(786)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988590/
http://dx.doi.org/10.1016/j.healun.2022.01.807

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988590/
http://dx.doi.org/10.1016/j.healun.2022.01.807

Ejemplares similares